REG - CVS Group plc - Grant of Options & PDMR Dealing

CVSAnnouncement

26/11/2024 14:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241126:nRSZ7314Na&default-theme=true

RNS Number : 7314N  CVS Group plc  26 November 2024

 

 

26 November 2024

CVS Group plc

("CVS" or the "Company")

 

Grant of Options under CVS Group plc SAYE Option Scheme & PDMR Dealing

CVS Group plc (the "Company") announces that as part of its 2024/2025 Save As
You Earn share scheme (the "SAYE Scheme"), which is open to all employees of
the Group, the Executive Directors named below have elected to participate in
the SAYE Scheme and have been granted SAYE Scheme options as follows:

 

Richard Fairman
            722 SAYE scheme options

Robin Alfonso
                700 SAYE scheme options

Paul Higgs
                    722 SAYE scheme options

 

Eligible employees were invited to subscribe for options over the Company's
ordinary shares of 0.2 pence each ("Ordinary Shares") with an exercise price
of  847 pence per share, representing a 10% discount to the average closing
middle market price for the three dealing days prior to 1 November 2024, being
the invitation date.

 

In response to accepted invitations, a total of 612,781 SAYE Scheme options
over Ordinary Shares were granted on 26 November 2024, equating to 0.86% of
the current issued ordinary share capital.  Subject to the rules of the SAYE
Scheme, these options will be capable of exercise from the maturity date on 1
January 2028.

 

The notification below, made in accordance with the requirements of UK MAR,
provides further detail.

 

 Contacts:

CVS Group plc
 
           via Camarco

Richard Fairman, CEO

Scott Morrison Group Company Secretary

 

Peel Hunt LLP (Nominated Adviser & Broker)
                               +44 (0)20 7418 8900

Christopher Golden / James Steel / Andrew Clark / Lalit Bose

 

Berenberg (Joint
Broker)
+44 (0)20 3207 7800

Toby Flaux / Ben Wright / Ciaran Walsh / Milo Bonser

 

Camarco (Financial
PR)

Geoffrey Pelham-Lane
 
      +44 (0)7733 124 226

Ginny Pulbrook
 
             +44 (0)7961 315 138

 

 

 

Notification and public disclosure of transactions by persons discharging
managerial responsibilities and persons closely associated with them

 

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                         Richard Fairman
 2   Reason for the notification
 a)  Position/status                                              Chief Executive Officer
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         CVS Group plc
 b)  LEI                                                          213800J41XDQ2NX48O05
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Options over Ordinary shares of 0.2 pence each

     Identification code

                                                                  GB00B2863827
 b)  Nature of the transaction                                    Grant of Options under the SAYE Scheme.
 c)  Price(s) and volume(s)                                       Price(s)                Volume(s)
                                                                  Exercise price of 847p  722

 

 d)  Aggregated information

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      26 November 2024
 f)  Place of the transaction                                     Off market

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

26 November 2024

f)

Place of the transaction

Off market

 

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                         Robin Alfonso
 2   Reason for the notification
 a)  Position/status                                              Chief Financial Officer
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         CVS Group plc
 b)  LEI                                                          213800J41XDQ2NX48O05
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Options over Ordinary shares of 0.2 pence each

     Identification code

                                                                  GB00B2863827
 b)  Nature of the transaction                                    Grant of Options under the SAYE Scheme.
 c)  Price(s) and volume(s)                                       Price(s)                Volume(s)
                                                                  Exercise price of 847p  700

 

 d)  Aggregated information

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      26 November 2024
 f)  Place of the transaction                                     Off market

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

26 November 2024

f)

Place of the transaction

Off market

 

 

 1   Details of the person discharging managerial responsibilities / person closely
     associated
 a)  Name                                                         Paul Higgs
 2   Reason for the notification
 a)  Position/status                                              Chief Veterinary Officer & Director
 b)  Initial notification /Amendment                              Initial Notification
 3   Details of the issuer, emission allowance market participant, auction
     platform, auctioneer or auction monitor
 a)  Name                                                         CVS Group plc
 b)  LEI                                                          213800J41XDQ2NX48O05
 4   Details of the transaction(s): section to be repeated for (i) each type of
     instrument; (ii) each type of transaction; (iii) each date; and (iv) each
     place where transactions have been conducted
 a)  Description of the financial instrument, type of instrument  Options over Ordinary shares of 0.2 pence each

     Identification code

                                                                  GB00B2863827
 b)  Nature of the transaction                                    Grant of Options under the SAYE Scheme.
 c)  Price(s) and volume(s)                                       Price(s)                Volume(s)
                                                                  Exercise price of 847p

                                                                              722

 

 d)  Aggregated information

     - Aggregated volume

     - Price
 e)  Date of the transaction                                      26 November 2024
 f)  Place of the transaction                                     Off market

 

 

 

d)

Aggregated information

 

- Aggregated volume

 

 

- Price

e)

Date of the transaction

26 November 2024

f)

Place of the transaction

Off market

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHXQLFLZFLEFBZ